Complement as effector system in cancer immunotherapy Paolo Macor, Francesco Tedesco ∗
Competition of Charge-Mediated and Specific Binding by
Competent Care for the Dying Instead of Physician
Compensatory Pathways Induced by MEK Inhibition Are Effective
Compendium of Chemical Hazards
Compelling evidence for a prostate cancer gene at 22q12.3 by the
Compassionate Drug Use
Compass Cancer Brochure - University Centers of Excellence
Compartment-Specific Roles of ATP-Binding
Comparison of Water and Lipid Content Measurements Using
Comparison of various different chemotherapy regimens in triple
Comparison of Treatment Costs for Breast Cancer
Comparison of TP53 Mutations Identified by
Comparison of the Spatial Organization in Colorectal Tumors using
Comparison of the Short-Term Biological Effects
Comparison of systemic therapies used concurrently with radiation
Comparison of serum testosterone levels in prostate cancer patients
Comparison of Recommendations by Urologists and
Comparison of radiotherapy alone with radiotherapy plus
Comparison of Radiotherapy Alone With Radiotherapy First Results of Triple-Modality Treatment
